Both in Pharmaceuticals
Rapport Therapeutics vs Eton Pharmaceutcials
Over the past year RAPP returned −5.6% and ETON returned +183.7%; their daily moves had a correlation of 0.13.
RAPP −5.6% ETON +183.7%Growth of $1, one year, split-adjusted
| Metric | RAPP | ETON |
|---|---|---|
| Price | $25.44 | $50.95 |
| Market cap | $1.43B | $1.46B |
| Today | +1.23% | +0.28% |
| 1 month | −21.0% | −8.4% |
| 6 months | −28.5% | +67.7% |
| Year to date | −16.2% | +201.3% |
| 1 year | −12.1% | +182.9% |
| Revenue growth (YoY) | — | +98.6% |
| Gross margin | — | 67.6% |
| Net margin | — | 30.8% |
| P/E (TTM) | — | 114.8× |
| Price / sales | 71.6× | 13.8× |
| Net cash | $436.1M | -$1.1M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 90.0% |
| Short % of float | 10.9% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).